Novartis May Still Spin Off Alcon, but Not Before 2019

The Swiss pharmaceutical giant has delayed a possible spin off of its eyecare division Alcon until the first half of 2019, amid signs of a turnaround in the ailing business.

from WSJ.com: US Business http://ift.tt/2yFOqUk
via IFTTT